Evaluation of role of gnrh antagonist in intrauterine insemination (IUI) cycles with mild ovarian hyperstimulation (MOH) (original) (raw)

GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial

Francesca Sammartano

Human Reproduction, 2006

View PDFchevron_right

The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial

Donatella Caserta

Human Reproduction, 2011

View PDFchevron_right

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles

Anne Zedeler

Human Reproduction, 2016

View PDFchevron_right

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

Walter Vegetti

Human Reproduction, 2005

View PDFchevron_right

Study of positive and negative consequences of using GnRH antagonist in intrauterine insemination cycle

maryam bagheri

View PDFchevron_right

The addition of GnRH antagonists in intrauterine insemination cycles: a pilot study

Roberto Marci

PubMed, 2013

View PDFchevron_right

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF

Raoul Orvieto

Frontiers in Endocrinology, 2020

View PDFchevron_right

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

Claudio Benadiva

Fertility and Sterility, 2008

View PDFchevron_right

GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol

Raoul Orvieto

Gynecologic and Obstetric Investigation, 2021

View PDFchevron_right

Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF

E. Kolibianakis, Johan Schiettecatte

Human Reproduction, 2004

View PDFchevron_right

Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy

Judith Huirne

Human Reproduction, 2004

View PDFchevron_right

Antagonist use in intrauterine insemination (IUI) cycles

Nur Dokuzeylül Güngör

Journal of the Turkish-German Gynecological Association, 2009

View PDFchevron_right

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome

Carmina Vidal, Juan Giles

International Journal of Endocrinology and Metabolism, 2013

View PDFchevron_right

Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial

Frank Broekmans

Human Reproduction, 2013

View PDFchevron_right

Comparison of Dydrogesterone and GnRH Antagonists for Prevention of Premature LH Surge in IVF/ICSI Cycles: A Randomized Controlled Trial

Bita Eslami

Journal of Family & Reproductive Health, 2020

View PDFchevron_right

GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori

Shimon Scharf, Raoul Orvieto

Fertility and Sterility, 2009

View PDFchevron_right

Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes

Michael Kruger

Journal of Assisted Reproduction and Genetics, 2008

View PDFchevron_right

In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF

Haris E . Cazlaris

Human Reproduction, 2005

View PDFchevron_right

Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome

murat sonmezer

Reproductive BioMedicine Online, 2017

View PDFchevron_right

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles. Systematic review & meta-analysis

Mohamed Ahmed

Journal of Advanced Research, 2015

View PDFchevron_right

Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study

Deepika Krishna

Journal of reproduction & infertility, 2012

View PDFchevron_right

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis

mohamed youssef

Journal of Advanced Research, 2015

View PDFchevron_right

GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial

Yannis Panagiotidis

Journal of Assisted Reproduction and Genetics, 2017

View PDFchevron_right

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome

ayten türkkanı

Gynecology Obstetrics and Reproductive Medicine, 2016

View PDFchevron_right

Addition of GnRH antagonist in cycles of poor responders undergoing IVF

Esra Aksoy, Halit Erden

Human Reproduction, 2000

View PDFchevron_right

Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial

Abdelhamid BENMACHICHE

Frontiers in Endocrinology

View PDFchevron_right

The effects of adding Gonadotropin-releasing Hormone antagonist on cycle characteristics and pregnancy rate in stimulated Intrauterine Insemination (IUI) cycle

muayad sraibet

International Journal of Research in Pharmaceutical Sciences, 2020

View PDFchevron_right

GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages

Edgardo Somigliana

Human Reproduction, 2004

View PDFchevron_right